VBP
ABPI outlines vision for drug pricing reform
August 3, 2012Sales and Marketing ABPI, NICE, PPRS, VBP, Whitehead, value-based pricing
The ABPI has set out what it wants to see from the new drug pricing system in the UK. Negotiations …
New UK drug pricing system will ‘stifle innovation’
August 2, 2012Sales and Marketing ABPI, PPRS, UK government, VBP
The ABPI has attacked the UK government’s new drug pricing policy, saying it will not benefit the pharma industry. Value-Based …
Sluggish growth forecast concerns ABPI
July 3, 2012Sales and Marketing ABPI, NHS, OHE, VBP, government
New forecasts suggest that spending on branded drugs may fall in real terms by 2015, leading the ABPI to call …
ABPI to no longer ‘shy away’ from big issues
June 27, 2012Medical Communications, Sales and Marketing ABPI, Callaghan, NHS, VBP, Whitehead
The ABPI will actively seek to tackle tough issues like animal testing and clinical trial problems, as it looks to …
The European Medicines Group: focused on UK market access
June 25, 2012Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing ABPI, EMG, NICE, VBP, market access
Maintaining a dialogue with government, NHS organisations and other stakeholder groups is essential for pharma companies in the UK, and …
UK drug pricing: ABPI wants evolution, not revolution
June 14, 2012Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing ABPI, Deepak Khanna, MSD, PPRS, VBP, pricing
As the ABPI prepares to negotiate a new pricing scheme for the first time in 50 years, its new president …
ABPI ‘fears for future of UK research’ ahead of pricing talks
June 7, 2012Sales and Marketing ABPI, Drug pricing, PPRS, Stephen Whitehead, VBP
The UK pharmaceutical industry says too great a focus on ‘breakthrough’ drugs could undermine the future of medical research in …
NICE to be sidelined on cost effectiveness – once again
May 17, 2012Sales and Marketing NICE, VBP
Health secretary Andrew Lansley has confirmed that NICE will no longer direct the NHS on the cost effectiveness of drugs. …
ABPI appoints Catherine Meaden as head of policy and public affairs
March 6, 2012Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing ABPI, NHS Direct, VBP
The ABPI has appointed Catherine Meaden as its new head of policy and public affairs. She will join the UK …
UK pharma downbeat on its future – survey
November 8, 2011Research and Development ABPI, R&D, VBP, rsa
The impacts of NHS reform and the increasingly high cost of R&D is causing pharma to doubt its future in …
NHS Confederation: value-based pricing could increase NHS costs
March 18, 2011Sales and Marketing NHS Confederation, PPRS, Pharmaceutical Price Regulation Scheme, UK drug pricing, VBP, value-based pricing
Government plans to introduce value-based pricing in the UK could increase the NHS drugs bill without improving the effectiveness of …
Pharma industry wary of UK drug pricing changes
March 17, 2011Sales and Marketing ABPI, National Voices, PPRS, Pharmaceutical Price Regulation Scheme, Simon Jose, UK drug pricing, VBP, value-based pricing
The ABPI wants the current drug pricing system to remain, but has welcomed government proposals to take a broader view …
UK pharma faces rising costs from value-based pricing
December 3, 2010Sales and Marketing Eli Lilly, VBP, lilly, value-based pricing
The government’s planned introduction of a value-based pricing system in the UK could increase costs and bureaucracy for the industry, …
NICE: the end of an era
August 9, 2010Sales and Marketing Andrew Lansley, NICE, VBP, government
NICE is undergoing a momentus shift in its role which will see it leave behind the frequent clashes and controversy …
Latest content
Boyds expands Regulatory Affairs team to support growing demand
Sterling doubles ADC manufacturing capacity at Welsh facility
Femtosecond laser cuts lung tumour margin assessment time
Blood sensor detects Parkinson’s-associated proteins in 40 minutes
